Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 70 (1) , 107-110
- https://doi.org/10.1016/s0015-0282(98)00121-6
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effect of 12-Month Dehydroepiandrosterone Replacement Therapy on Bone, Vagina, and Endometrium in Postmenopausal WomenJournal of Clinical Endocrinology & Metabolism, 1997
- Delivery of dehydroepiandrosterone to premenopausal women: Effects of micronization and nonoral administrationAmerican Journal of Obstetrics and Gynecology, 1996
- DHEA Administration to Humans: Panacea or Palaver?Seminars in Reproductive Medicine, 1995
- Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal womenFertility and Sterility, 1995
- Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1993
- Cancer chemoprevention with the adrenocortical steroid dehydroepiandrosterone and structural analogsJournal of Cellular Biochemistry, 1993
- Postmenopausal steroid replacement with micronized dehydroepiandrosterone: Preliminary oral bioavailability and dose proportionality studiesAmerican Journal of Obstetrics and Gynecology, 1992
- Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.Journal of Clinical Investigation, 1988
- Dehydroepiandrosterone sulfate improves memory in aging miceBrain Research, 1988